The Cigna Group (NYSE:CI) Shares Sold by Teza Capital Management LLC

Teza Capital Management LLC reduced its position in The Cigna Group (NYSE:CI - Free Report) by 94.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 753 shares of the health services provider's stock after selling 12,242 shares during the period. Teza Capital Management LLC's holdings in The Cigna Group were worth $208,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of CI. Hennion & Walsh Asset Management Inc. raised its position in shares of The Cigna Group by 35.4% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 1,068 shares of the health services provider's stock valued at $295,000 after purchasing an additional 279 shares during the last quarter. Merit Financial Group LLC raised its position in shares of The Cigna Group by 15.7% in the 4th quarter. Merit Financial Group LLC now owns 2,333 shares of the health services provider's stock valued at $644,000 after purchasing an additional 316 shares during the last quarter. UMB Bank n.a. raised its position in shares of The Cigna Group by 3.2% in the 4th quarter. UMB Bank n.a. now owns 4,343 shares of the health services provider's stock valued at $1,199,000 after purchasing an additional 136 shares during the last quarter. Harbor Investment Advisory LLC raised its position in shares of The Cigna Group by 4.2% in the 4th quarter. Harbor Investment Advisory LLC now owns 1,797 shares of the health services provider's stock valued at $496,000 after purchasing an additional 72 shares during the last quarter. Finally, Pure Financial Advisors LLC raised its position in shares of The Cigna Group by 16.4% in the 4th quarter. Pure Financial Advisors LLC now owns 1,045 shares of the health services provider's stock valued at $289,000 after purchasing an additional 147 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CI has been the subject of several research analyst reports. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a research report on Friday, January 31st. Guggenheim reaffirmed a "buy" rating and issued a $388.00 price objective on shares of The Cigna Group in a research report on Friday. Mizuho lifted their price objective on shares of The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. UBS Group decreased their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Finally, Cantor Fitzgerald lifted their price objective on shares of The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research note on Thursday, March 20th. Two analysts have rated the stock with a hold rating, sixteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $379.33.

Insider Transactions at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of The Cigna Group stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Noelle K. Eder sold 9,944 shares of The Cigna Group stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the sale, the insider now owns 13,406 shares of the company's stock, valued at $4,289,920. This trade represents a 42.59% decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock worth $13,603,991 over the last 90 days. 0.70% of the stock is currently owned by insiders.

The Cigna Group Trading Down 0.5%

Shares of CI stock traded down $1.52 on Tuesday, hitting $314.47. 295,056 shares of the stock traded hands, compared to its average volume of 1,809,651. The firm's 50-day moving average price is $325.26 and its two-hundred day moving average price is $309.92. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The stock has a market capitalization of $84.01 billion, a PE ratio of 25.69, a PEG ratio of 0.98 and a beta of 0.47. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The company had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same period in the prior year, the firm earned $6.47 earnings per share. The business's revenue for the quarter was up 14.4% compared to the same quarter last year. As a group, analysts anticipate that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 1.92%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio (DPR) is presently 33.44%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.